Infection Control & Biosafety Products Market, 2018-2023 – In 2018, Combined Global Sales of Injection Devices Totaled $2.7Bn, with Safety Needles & Syringes Accounting for Nearly 90% of Sales

Ads

You May Also Like

FIT Biotech Oy: FIT Biotech concludes the exploration of secondary listing to First North Sweden -not relevant at the moment

FIT Biotech Oy                                                             Company release 16.8.2018 at 4:30 PM EET FIT Biotech concludes the ...

ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC®

ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC®, an immunotherapy antibody ...

Celsion Corporation to Hold Year-End 2016 Financial Results Conference Call on Thursday, March 16, 2017

LAWRENCEVILLE, N.J., March 09, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN) announced today that ...